[{"NetIncomeLoss_3_Q3_USD":-20315244.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":57401387.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":59105399.0,"AccruedLiabilitiesCurrent_0_Q3_USD":2968994.0,"AssetsCurrent_0_Q3_USD":31630256.0,"ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_3_Q3_USD":2980456.0,"ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_1_Q3_USD":1319913.0,"GeneralAndAdministrativeExpense_1_Q3_USD":1381477.0,"LeaseAndRentalExpense_3_Q3_USD":169469.0,"CommonStockSharesIssued_0_Q3_shares":60082291.0,"Assets_0_Q3_USD":31630256.0,"ShareBasedCompensation_3_Q3_USD":4216306.0,"StockIssuedDuringPeriodValueAcquisitions_3_Q3_USD":20490297.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q3_USD":5124805.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LeaseAndRentalExpense_1_Q3_USD":58554.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":20490297.0,"GeneralAndAdministrativeExpense_3_Q3_USD":4453654.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":178332979.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-62367.0,"PrepaidExpenseCurrent_0_Q3_USD":438631.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":1452652.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.978,"Cash_0_Q3_USD":27619145.0,"CommonStockValue_0_Q3_USD":60083.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-24182.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":248665.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":20465789.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":456872.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0157,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":27619145.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":5433515.0,"ResearchAndDevelopmentExpense_1_Q3_USD":6725002.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"IncomeTaxesReceivable_0_Q3_USD":3547972.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-20301213.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-6481805.0,"InterestIncomeExpenseNet_3_Q3_USD":172996.0,"InterestIncomeExpenseNet_1_Q3_USD":56096.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":4216306.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1251129.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":500000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-15032274.0,"AccountsPayableCurrent_0_Q3_USD":3980204.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":24508.0,"NonoperatingIncomeExpense_3_Q3_USD":3279158.0,"NonoperatingIncomeExpense_1_Q3_USD":1624674.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3_Q3_shares":10576266.0,"NetIncomeLoss_1_Q3_USD":-6486622.0,"LiabilitiesCurrent_0_Q3_USD":6949198.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"CommonStockSharesOutstanding_0_Q3_shares":60082291.0,"CurrentIncomeTaxExpenseBenefit_3_Q3_USD":14031.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":905227.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"PreferredStockValue_0_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":31630256.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1251129.0,"CurrentIncomeTaxExpenseBenefit_1_Q3_USD":4817.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4216306.0,"OperatingExpenses_1_Q3_USD":8106479.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.35,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.11,"StockholdersEquity_0_Q3_USD":24681058.0,"DeferredCostsCurrent_0_Q3_USD":24508.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-153712004.0,"OperatingExpenses_3_Q3_USD":23580371.0,"ResearchAndDevelopmentExpense_3_Q3_USD":19126717.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]